𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of basic oral care and good clinical practice principles in the management of oral mucositis

✍ Scribed by Deborah B. McGuire; Maria Elvira P. Correa; Judith Johnson; Patricia Wienandts

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
113 KB
Volume
14
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical practice guidelines for the pre
Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis
✍ Edward B. Rubenstein; Douglas E. Peterson; Mark Schubert; Dorothy Keefe; Deborah πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 2 views

## BACKGROUND. Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, 80% of patients with malignancies of the head and neck receiving radiotherapy, and a wide range of patients receiving chemotherap

THE ROLE OF GENERAL PRACTICE AND THE PRI
THE ROLE OF GENERAL PRACTICE AND THE PRIMARY CARE TEAM IN DEMENTIA DIAGNOSIS AND MANAGEMENT
✍ MURNA G. DOWNS πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 602 KB

General practitioners (GPs) and the primary care team are uniquely situated to play a central role both in the diagnosis and ongoing care of dementia. Anecdotal reports and empirical work suggest that GPs face several challenges in fulfilling this role. This paper describes the various roles GPs and

Advances in the monitoring of oral antic
Advances in the monitoring of oral anticoagulation: Point-of-care testing, patient self-monitoring, and patient self-management
✍ Katharine E. Leaning; Jack E. Ansell πŸ“‚ Article πŸ“… 1996 πŸ› Springer US 🌐 English βš– 748 KB

Oral anticoagulation with warfarin sodium has proven to be an effective therapy for patients at risk for thromboembolic disease, but due to its high risk/benefit ratio, many physicians are reluctant to prescribe the drug. The development of capillary whole-blood prothrombin time (PT) monitors provid